A 3-Year Survival Update from a Phase 2 Study of Paclitaxel Plus Cisplatin and 5-Fuorouracil Induction Chemotherapy for Locally Advanced Borderline-Resectable Esophageal Squamous Cell Carcinoma: The NEOCRTEC-1601 Clinical Trial
CONCLUSION: Long-term follow-up evaluation confirmed that TPF followed by surgery is feasible and promising in terms of survival for BR-ESCC patients. Trial Registration ClinicalTrials.gov identifer: NCT02976909.PMID:37919448 | DOI:10.1245/s10434-023-14513-0 (Source: Ann Oncol)
Source: Ann Oncol - November 3, 2023 Category: Cancer & Oncology Authors: Jia-Di Wu Zhi-Qiang Wang Qiao-Qiao Li Zhi-Chao Li Chao Ren De-Shen Wang Ji-Yang Chen Qiong Tan Yu-Hong Li Hong Yang Source Type: research
A 3-Year Survival Update from a Phase 2 Study of Paclitaxel Plus Cisplatin and 5-Fuorouracil Induction Chemotherapy for Locally Advanced Borderline-Resectable Esophageal Squamous Cell Carcinoma: The NEOCRTEC-1601 Clinical Trial
CONCLUSION: Long-term follow-up evaluation confirmed that TPF followed by surgery is feasible and promising in terms of survival for BR-ESCC patients. Trial Registration ClinicalTrials.gov identifer: NCT02976909.PMID:37919448 | DOI:10.1245/s10434-023-14513-0 (Source: Ann Oncol)
Source: Ann Oncol - November 3, 2023 Category: Cancer & Oncology Authors: Jia-Di Wu Zhi-Qiang Wang Qiao-Qiao Li Zhi-Chao Li Chao Ren De-Shen Wang Ji-Yang Chen Qiong Tan Yu-Hong Li Hong Yang Source Type: research
A 3-Year Survival Update from a Phase 2 Study of Paclitaxel Plus Cisplatin and 5-Fuorouracil Induction Chemotherapy for Locally Advanced Borderline-Resectable Esophageal Squamous Cell Carcinoma: The NEOCRTEC-1601 Clinical Trial
CONCLUSION: Long-term follow-up evaluation confirmed that TPF followed by surgery is feasible and promising in terms of survival for BR-ESCC patients. Trial Registration ClinicalTrials.gov identifer: NCT02976909.PMID:37919448 | DOI:10.1245/s10434-023-14513-0 (Source: Ann Oncol)
Source: Ann Oncol - November 3, 2023 Category: Cancer & Oncology Authors: Jia-Di Wu Zhi-Qiang Wang Qiao-Qiao Li Zhi-Chao Li Chao Ren De-Shen Wang Ji-Yang Chen Qiong Tan Yu-Hong Li Hong Yang Source Type: research
A 3-Year Survival Update from a Phase 2 Study of Paclitaxel Plus Cisplatin and 5-Fuorouracil Induction Chemotherapy for Locally Advanced Borderline-Resectable Esophageal Squamous Cell Carcinoma: The NEOCRTEC-1601 Clinical Trial
ConclusionLong-term follow-up evaluation confirmed that TPF followed by surgery is feasible and promising in terms of survival for BR-ESCC patients.Trial Registration ClinicalTrials.gov identifer: NCT02976909. (Source: Annals of Surgical Oncology)
Source: Annals of Surgical Oncology - November 2, 2023 Category: Cancer & Oncology Source Type: research
10292 Paratubal Borderline Tumor in Adolescence - A Case Report and Review of Literature.
Review the incidence, clinical presentation, diagnosis and treatment of Para-tubal borderline tumors in adolescent patients. (Source: The Journal of Minimally Invasive Gynecology)
Source: The Journal of Minimally Invasive Gynecology - October 27, 2023 Category: OBGYN Authors: A Saad, S Alameri, S Ricci Source Type: research
Tumor necrosis factor-alpha mediates the negative association between telomere length and kidney dysfunction
Conclusion: Baseline LTL could independently predict kidney dysfunction at follow-up, especially in participants with hypertension. TNF-a partially mediated the negative association between LTL and kidney dysfunction.PMID:37859695 | PMC:PMC10583187 | DOI:10.7150/ijms.87254 (Source: International Journal of Medical Sciences)
Source: International Journal of Medical Sciences - October 20, 2023 Category: Biomedical Science Authors: Mengya Qi Jie Yu Fan Ping Lingling Xu Wei Li Huabing Zhang Yuxiu Li Source Type: research
